UBE2M and osteosarcoma: Research has shown that the expression levels of NEDD8-activating enzyme E1 (NAE1) and ubiquitin-conjugating enzyme E2M (UBE2M) are significantly higher in osteosarcoma tissues and cells compared to normal bone tissues and cells, potentially contributing to the onset and progression of osteosarcoma.